Headline News about Esperion Theraptc
The Latest Analyst Ratings for Esperion Therapeutics
February 27, 2023
Via Benzinga
Looking Into Esperion Therapeutics's Return On Capital Employed
February 22, 2023
Via Benzinga
Esperion Therapeutics's Earnings Outlook
February 20, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Via Benzinga
Esperion Therapeutics Reports Sooner Than Expected Positive Data From Nexletol Trial
December 07, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|